Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.18
+0.52 (9.19%)
Jun 30, 2026, 4:00 PM EDT - Market closed
Abeona Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.4 | 5.82 | - | 3.5 | 1.41 | 3 | |
Revenue Growth (YoY) | - | - | - | 147.53% | -52.87% | -70.00% |
Cost of Revenue | 1.89 | 3.43 | - | 1.61 | 0.45 | - |
Gross Profit | 1.51 | 2.4 | - | 1.9 | 0.96 | 3 |
Selling, General & Admin | 74.75 | 65.03 | 29.85 | 19 | 17.26 | 21.64 |
Research & Development | 26.43 | 26.81 | 34.36 | 31.09 | 28.97 | 38.73 |
Other Operating Expenses | - | - | - | -1.07 | 5.66 | 32.47 |
Total Operating Expenses | 101.17 | 91.84 | 64.21 | 49.03 | 51.88 | 92.84 |
Operating Income | -99.67 | -89.45 | -64.21 | -47.14 | -50.92 | -89.84 |
Interest Income | 5.6 | 5.56 | 4.25 | 2.12 | 0.43 | 0.04 |
Interest Expense | -3.57 | -3.74 | -4.21 | -0.42 | -0.74 | -3.66 |
Other Non-Operating Income (Expense) | 156.86 | 158.92 | 0.44 | -8.75 | 11.52 | 8.52 |
Total Non-Operating Income (Expense) | 158.89 | 160.73 | 0.48 | -7.05 | 11.22 | 4.9 |
Pretax Income | 59.23 | 71.28 | -63.73 | -54.19 | -39.7 | -84.94 |
Provision for Income Taxes | 0.1 | 0.1 | - | - | - | - |
Net Income | -22.24 | 71.18 | -63.73 | -54.19 | -39.7 | -84.94 |
Net Income Attributable to Preferred Dividends | - | - | - | - | 3.78 | - |
Net Income to Common | -22.24 | 71.18 | -63.73 | -54.19 | -43.48 | -84.94 |
Shares Outstanding (Basic) | 55 | 53 | 41 | 21 | 8 | 4 |
Shares Outstanding (Diluted) | 61 | 66 | 41 | 21 | 8 | 4 |
Shares Change (YoY) | 23.73% | 61.12% | 91.99% | 171.96% | 99.65% | 6.24% |
EPS (Basic) | 1.25 | 1.34 | -1.55 | -2.53 | -5.53 | -21.57 |
EPS (Diluted) | 0.97 | 1.01 | -1.55 | -2.53 | -5.53 | -21.57 |
Free Cash Flow | -85.24 | -84.3 | -58.46 | -37.34 | -43.61 | -69.82 |
Free Cash Flow Per Share | -1.39 | -1.27 | -1.42 | -1.75 | -5.55 | -17.73 |
Gross Margin | 44.32% | 41.15% | - | 54.14% | 68.18% | 100.00% |
Operating Margin | -2931.35% | -1536.91% | - | -1346.71% | -3600.78% | -2994.53% |
Profit Margin | -654.00% | 1223.08% | - | -1548.23% | -2807.36% | -2831.20% |
FCF Margin | -2506.97% | -1448.47% | - | -1066.86% | -3084.37% | -2327.20% |
EBITDA | -96.96 | -86.9 | -62.21 | -44.85 | -47.82 | -86.59 |
EBITDA Margin | -2851.79% | -1493.11% | - | -1281.34% | -3382.04% | -2886.20% |
EBIT | -99.67 | -89.45 | -64.21 | -47.14 | -50.92 | -89.84 |
EBIT Margin | -2931.35% | -1536.91% | - | -1346.71% | -3600.78% | -2994.53% |
Effective Tax Rate | 0.17% | 0.14% | 0.00% | 0.00% | 0.00% | 0.00% |